Join
Live feed
·
PRReleasevia Quantisnow
Celularity Inc. logo
NexGel Inc logo

NEXGEL New Strategic Partner, Sequence LifeScience™, Leads Financing with $5.5 Million to Complete Acquisition of Celularity Degenerative Disease Segment

ByQuantisnow·Wall Street's wire, on your screen.
CELU· Celularity Inc.NXGL· NexGel Inc
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CELU (Celularity Inc.), NXGL (NexGel Inc) and more on Quantisnow.